Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Journal of Molecular Graphics & Modelling
|
September 15, 2004
Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling
Maricel Torrent, Keith Rickert, Bo-Sheng Pan, et al.
Plos One
|
June 27, 2014
FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival
Anjili Mathur, Christopher Ware, Lenora Davis, et al.
The Journal of Biological Chemistry
|
March 30, 2019
A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism
My S Mansueto, Abigail Reens, Larissa Rakhilina, et al.
Journal of Biomolecular Screening
|
September 25, 2008
High-throughput analysis of HGF-stimulated cell scattering
Grace K Y Chan, Bart A Lutterbach, Bo-Sheng Pan, et al.
Cancer Research
|
March 3, 2007
Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival
Bart Lutterbach, Qinwen Zeng, Lenora J Davis, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING
Tony Siu, Michael D Altman, Gretchen A Baltus, et al.
The American Journal of Pathology
|
May 22, 2010
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis
Elisa Benedettini, Lynette M Sholl, Michael Peyton, et al.
Emerging Microbes & Infections
|
March 7, 2022
A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity
Xin Wang, Xiaochen Yin, Boya Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 15, 2017
Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
Fiona Elwood, David J Witter, Jennifer Piesvaux, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Journal of Molecular Graphics & Modelling
|
September 15, 2004
Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling
Maricel Torrent, Keith Rickert, Bo-Sheng Pan, et al.
Plos One
|
June 27, 2014
FGFR2 is amplified in the NCI-H716 colorectal cancer cell line and is required for growth and survival
Anjili Mathur, Christopher Ware, Lenora Davis, et al.
The Journal of Biological Chemistry
|
March 30, 2019
A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism
My S Mansueto, Abigail Reens, Larissa Rakhilina, et al.
Journal of Biomolecular Screening
|
September 25, 2008
High-throughput analysis of HGF-stimulated cell scattering
Grace K Y Chan, Bart A Lutterbach, Bo-Sheng Pan, et al.
Cancer Research
|
March 3, 2007
Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival
Bart Lutterbach, Qinwen Zeng, Lenora J Davis, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo
Hiroshi Hirai, Hiroshi Sootome, Yoko Nakatsuru, et al.
ACS Medicinal Chemistry Letters
|
January 19, 2019
Discovery of a Novel cGAMP Competitive Ligand of the Inactive Form of STING
Tony Siu, Michael D Altman, Gretchen A Baltus, et al.
The American Journal of Pathology
|
May 22, 2010
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis
Elisa Benedettini, Lynette M Sholl, Michael Peyton, et al.
Emerging Microbes & Infections
|
March 7, 2022
A prophylactic effect of aluminium-based adjuvants against respiratory viruses via priming local innate immunity
Xin Wang, Xiaochen Yin, Boya Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 15, 2017
Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
Fiona Elwood, David J Witter, Jennifer Piesvaux, et al.
Page
of 2